Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia. / El Missiry, Mohamed; Adnan Awad, Shady; Rajala, Hanna L; Al-Samadi, Ahmed; Ekblom, Marja; Markevän, Berit; Åstrand-Grundström, Ingbritt; Wold, Maren; Svedahl, Ellen Rabben; Juhl, Birgitte Ravn; Bjerrum, Ole Weis; Haulin, Inger; Porkka, Kimmo; Olsson-Strömberg, Ulla; Hjorth-Hansen, Henrik; Mustjoki, Satu.

I: Journal of Cancer Research and Clinical Oncology, Vol. 142, Nr. 5, 2016, s. 1041-1050.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

El Missiry, M, Adnan Awad, S, Rajala, HL, Al-Samadi, A, Ekblom, M, Markevän, B, Åstrand-Grundström, I, Wold, M, Svedahl, ER, Juhl, BR, Bjerrum, OW, Haulin, I, Porkka, K, Olsson-Strömberg, U, Hjorth-Hansen, H & Mustjoki, S 2016, 'Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.', Journal of Cancer Research and Clinical Oncology, vol. 142, nr. 5, s. 1041-1050. https://doi.org/10.1007/s00432-015-2101-4

APA

CBE

El Missiry M, Adnan Awad S, Rajala HL, Al-Samadi A, Ekblom M, Markevän B, Åstrand-Grundström I, Wold M, Svedahl ER, Juhl BR, Bjerrum OW, Haulin I, Porkka K, Olsson-Strömberg U, Hjorth-Hansen H, Mustjoki S. 2016. Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia. Journal of Cancer Research and Clinical Oncology. 142(5):1041-1050. https://doi.org/10.1007/s00432-015-2101-4

MLA

Vancouver

Author

El Missiry, Mohamed ; Adnan Awad, Shady ; Rajala, Hanna L ; Al-Samadi, Ahmed ; Ekblom, Marja ; Markevän, Berit ; Åstrand-Grundström, Ingbritt ; Wold, Maren ; Svedahl, Ellen Rabben ; Juhl, Birgitte Ravn ; Bjerrum, Ole Weis ; Haulin, Inger ; Porkka, Kimmo ; Olsson-Strömberg, Ulla ; Hjorth-Hansen, Henrik ; Mustjoki, Satu. / Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia. I: Journal of Cancer Research and Clinical Oncology. 2016 ; Vol. 142, Nr. 5. s. 1041-1050.

RIS

TY - JOUR

T1 - Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.

AU - El Missiry, Mohamed

AU - Adnan Awad, Shady

AU - Rajala, Hanna L

AU - Al-Samadi, Ahmed

AU - Ekblom, Marja

AU - Markevän, Berit

AU - Åstrand-Grundström, Ingbritt

AU - Wold, Maren

AU - Svedahl, Ellen Rabben

AU - Juhl, Birgitte Ravn

AU - Bjerrum, Ole Weis

AU - Haulin, Inger

AU - Porkka, Kimmo

AU - Olsson-Strömberg, Ulla

AU - Hjorth-Hansen, Henrik

AU - Mustjoki, Satu

PY - 2016

Y1 - 2016

N2 - Tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukaemia have been reported to induce immunomodulatory effects. We aimed to assess peripheral blood (PB) and bone marrow (BM) lymphocyte status at the diagnosis and during different TKI therapies and correlate it with treatment responses.

AB - Tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukaemia have been reported to induce immunomodulatory effects. We aimed to assess peripheral blood (PB) and bone marrow (BM) lymphocyte status at the diagnosis and during different TKI therapies and correlate it with treatment responses.

U2 - 10.1007/s00432-015-2101-4

DO - 10.1007/s00432-015-2101-4

M3 - Article

VL - 142

SP - 1041

EP - 1050

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 1432-1335

IS - 5

ER -